Since its inception, MiCardia Corporation has built an experienced technical and clinical team, while creating a comprehensive intellectual property portfolio. The Company’s first generation product, enCor™, was developed as a dynamically activated annuloplasty device to correct residual mitral regurgitation, intra-operatively, on a beating heart.

A second generation device, using the dynamic technology, received CE Mark in 2011. The enCorSQ™ is unique in its ability to affect recurrent mitral regurgitation days, weeks, months or years after the implant procedure, without an additional surgery.

Learn More About MiCardia

Not available for sale in the US.
MICARDIA®, MICARDIA CORPORATION®, The M Logo®, ENCORSQ™, ENCORSQ MITRAL REPAIR SYSTEM™, DYNAPLASTY™ and DYNAPLASTY SYSTEM™ are trademarks of MiCardia Corporation. The ® symbol indicates that it is registered in the U.S. The ™ symbol indicates that the mark is not registered in the U.S.